Only a 1/3 of Patients take all their medicine...1/3 take some...1/3 none at all
Because of poor compliance, 25% of all patients who are prescribed medicines derive no clinical benefit whatsoever.
Because of poor compliance, 25% of all patients who are prescribed medicines derive no clinical benefit whatsoever. As a result, pharmaceutical companies bear a drastic fall in revenues. AXA Assistance, experts in delivering/ leading providers of patient communication programmes, can share more than 8 years' experience in tailoring and managing successful compliance programmes.
As part of the AXA Global Group and one of the world?s top 20 companies, our service centres operate 24/7/365 out of over 30 sites around the world, offering tailored solutions to the pharmaceutical industry. We have supported many brands and, with an average increase in compliance of 30%, demonstrated a profitable return on investment.
Our core services include:
- Compliance Programmes
- Product Support Programmes
- Medical Information Departments
- Issues Management Programmes
- Representative Sales Support
We believe that we have broken new ground by being the first company that truly meets all objectives of improving patient compliance. The principle aim is for patients and healthcare professionals to reap the benefits in turn deriving the maximum benefit for your brand. AXA Assistance ensure that the following is delivered as a minimum on all programmes implemented:
- Increased number of days on therapy demonstrating profitable return on Investment
- Confidence that the programme is regulatory compliant
- Consistent results associated with the medication evident due to enhanced compliance levels compared with other therapies
For further details contact:
Sunita Apte, Pharmaceutical Business Manger
Tel: +44 (0) 870 2406541
sunita.apte@axa-assistance.co.uk
Or visit www.axa-assistance.co.uk
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
